K Tatsumi Selected Research

K Tatsumi Research Topics

Disease

8	Neoplasms (Cancer) 10/2015 - 11/2001
3	Pulmonary Hypertension 01/2005 - 02/2000
3	Chronic Obstructive Pulmonary Disease (COPD) 08/2002 - 01/2000
2	Lung Diseases (Lung Disease) 06/2018 - 03/2001
2	Hemorrhage 01/2016 - 11/2013
2	Infections 01/2016 - 01/2015
2	Peritonitis 01/2015 - 03/2011
2	Mesothelioma 11/2014 - 03/2012
2	Allergic Rhinitis 02/2014 - 01/2007
2	Carcinoma (Carcinomatosis) 01/2014 - 11/2004
2	Hemophilia A (Haemophilia) 11/2013 - 08/2008
2	Hypoxia (Hypoxemia) 08/2002 - 11/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2015
1	Anastomotic Leak 01/2015
1	Melanoma (Melanoma, Malignant) 01/2014
1	Hemophilia B (Haemophilia B) 11/2013
1	Malignant Mesothelioma 03/2012
1	Inflammation (Inflammations) 11/2011
1	Pre-Eclampsia (Preeclampsia) 10/2011
1	Choriocarcinoma 10/2011
1	Hypertension (High Blood Pressure) 06/2011
1	Endometriosis 04/2011
1	Fibrosarcoma 01/2010
1	Neuroblastoma 08/2005
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2005
1	Neoplasm Metastasis (Metastasis) 11/2004
1	Rheumatoid Arthritis 02/2003
1	Renal Insufficiency (Renal Failure) 01/2003
1	Lung Neoplasms (Lung Cancer) 01/2003
1	Body Weight (Weight, Body) 08/2002
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2001
1	Carcinogenesis 11/2001
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 10/2001
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 05/2001
1	Peroxisome biogenesis disorders 03/2001

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2014 - 12/2000
2	AntigensIBA 10/2015 - 01/2001
2	InterleukinsIBA 10/2015 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 09/2000
2	NitrogenIBA 11/2014 - 08/2002
2	Cisplatin (Platino)FDA LinkGeneric 03/2012 - 01/2003
2	Small Interfering RNA (siRNA)IBA 01/2010 - 08/2005
1	MacrolidesIBA 06/2018
1	Thromboplastin (Tissue Factor)IBA 01/2016
1	Hemostatics (Antihemorrhagics)IBA 01/2016
1	SurvivinIBA 09/2015
1	CaspasesIBA 09/2015
1	MidkineIBA 09/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2014
1	Monomeric GTP-Binding ProteinsIBA 11/2014
1	Diphosphonates (Bisphosphonates)IBA 11/2014
1	Zoledronic Acid (Zometa)FDA Link 11/2014
1	Immunoglobulin E (IgE)IBA 02/2014
1	OvalbuminIBA 02/2014
1	interleukin-22 receptor (IL-22R)IBA 01/2014
1	Cyclin-Dependent Kinase Inhibitor p16IBA 03/2012
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 03/2012
1	Pemetrexed (MTA)FDA Link 03/2012
1	ChemokinesIBA 11/2011
1	Nerve Growth Factors (Neurotrophins)IBA 10/2011
1	Messenger RNA (mRNA)IBA 10/2011
1	Branched-Chain Amino AcidsIBA 06/2011
1	Progesterone FDA LinkGeneric 04/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2011
1	urinastatin (MR 20)IBA 03/2011
1	MethylcholanthreneIBA 01/2010
1	atelocollagenIBA 01/2010
1	Complementary DNA (cDNA)IBA 01/2010
1	Actins (F Actin)IBA 01/2010
1	Factor VIII (Coagulation Factor VIII)IBA 08/2008
1	Fas Ligand Protein (Fas Ligand)IBA 03/2007
1	Interleukin-4 (Interleukin 4)IBA 01/2007
1	Immunoglobulin G (IgG)IBA 01/2007
1	HLA-B Antigens (HLA-B)IBA 01/2005
1	HLA-B*52:01 antigenIBA 01/2005
1	Interleukin-22 (IL-22)IBA 11/2004
1	AutoantibodiesIBA 02/2003
1	Etoposide (VP 16)FDA LinkGeneric 01/2003
1	PlatinumIBA 01/2003
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2002
1	Anabolic AgentsIBA 08/2002
1	AntibodiesIBA 11/2001
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 11/2001
1	Monoclonal AntibodiesIBA 11/2001
1	SteroidsIBA 10/2001
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 05/2001
1	GangliosidesIBA 03/2001
1	beraprostIBA 03/2001
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2001

Therapy/Procedure

1	Immunotherapy 10/2015
1	Conservative Treatment 01/2015
1	Catheters 01/2015
1	Total Parenteral Nutrition 01/2015
1	Operative Surgical Procedures 11/2013
1	Laparotomy 11/2013
1	Immunomodulation 10/2011
1	High-Protein Diet 06/2011
1	Subcutaneous Injections 01/2010
1	Drug Therapy (Chemotherapy) 01/2003
1	Combination Drug Therapy (Combination Chemotherapy) 01/2003